These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 22259602)

  • 1. Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis.
    Jo HS; Park JS; Sohn JW; Yoon JC; Sohn CW; Lee SH; Hong GR; Shin DG; Kim YJ; Jeong MH; Chae SC; Hur SH; Hong TJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi DH; Jang YS; Yoon JH; Chung WS; Seung KB; Park SJ
    Korean Circ J; 2011 Dec; 41(12):718-25. PubMed ID: 22259602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2019 May; 284():102-109. PubMed ID: 30877937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.
    Iglesias JF; Muller O; Losdat S; Roffi M; Kurz DJ; Weilenmann D; Kaiser C; Heg D; Valgimigli M; Windecker S; Pilgrim T
    Int J Cardiol; 2021 Jul; 334():37-41. PubMed ID: 33887341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal Revascularization Strategy in Non-ST-Segment-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease: Culprit-Only Versus One-Stage Versus Multistage Revascularization.
    Kim MC; Hyun JY; Ahn Y; Bae S; Hyun DY; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Kim HS; Gwon HC; Seong IW; Hwang KK; Chae SC; Hur SH; Cha KS; Oh SK
    J Am Heart Assoc; 2020 Aug; 9(15):e016575. PubMed ID: 32750302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2020 May; 301():54-64. PubMed ID: 32330691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience.
    Khattab AA; Abdel-Wahab M; Röther C; Liska B; Toelg R; Kassner G; Geist V; Richardt G
    Clin Res Cardiol; 2008 Jan; 97(1):32-8. PubMed ID: 17694377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery-Only Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Kim HK; Hwang D; Lee SH; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Chae SC; Cho MC; Kim CJ; Kim JH; Kim HS; Gwon HC; Jeong MH; Hahn JY;
    J Am Heart Assoc; 2019 Dec; 8(24):e013870. PubMed ID: 31818215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction Registry.
    Lee HW; Hong TJ; Yang MJ; An SG; Oh JH; Choi JH; Lee HC; Cha KS; Hong JY;
    Cardiol J; 2012; 19(3):256-66. PubMed ID: 22641544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization.
    Kim MC; Jeong MH; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Cho SY; Rha SW; Bae JH; Cho JG; Park SJ;
    Int J Cardiol; 2011 Dec; 153(2):148-53. PubMed ID: 20843572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Hahn JY; Kim HK; Park J; Hwang D; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Kim YJ; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim JH; Kim HS; Jeong MH;
    J Am Coll Cardiol; 2018 Feb; 71(8):844-856. PubMed ID: 29471935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
    Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
    J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry.
    Galvão Braga C; Cid-Álvarez AB; Redondo Diéguez A; Trillo-Nouche R; Álvarez Álvarez B; López Otero D; Ocaranza Sánchez R; Gestal Romaní S; González Ferreiro R; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):425-432. PubMed ID: 27825718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete Versus Culprit-Only Revascularization for ST-Segment Elevation Myocardial Infarction and Multivessel Disease in the 2
    Kwon SW; Park SD; Moon J; Oh PC; Jang HJ; Park HW; Kim TH; Lee K; Suh J; Kang W
    Korean Circ J; 2018 Nov; 48(11):989-999. PubMed ID: 30334385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete revascularization versus culprit-only revascularization in ST-segment elevation myocardial infarction and multivessel disease patients undergoing primary percutaneous coronary intervention: A meta-analysis and trial sequential analysis.
    Wang CH; Zhang SY; Jin XF
    Int J Cardiol; 2017 Feb; 228():844-852. PubMed ID: 27907885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a meta-analysis of randomized trials.
    Xu H; Zhang X; Li J; Liu H; Hu X; Yang J
    BMC Cardiovasc Disord; 2019 Apr; 19(1):91. PubMed ID: 31010423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Culprit-only or multivessel percutaneous coronary stenting in patients with non-ST-segment elevation acute coronary syndromes: one-year follow-up.
    Zapata GO; Lasave LI; Kozak F; Damonte A; Meiriño A; Rossi M; Carbó S; Pollice A; Paolasso E; Picabea E
    J Interv Cardiol; 2009 Aug; 22(4):329-35. PubMed ID: 19515083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.